Patent US4382796A successfully refreshed from Google Patents.
Patent US4617308A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4617308A Expired / Lapsed US ⏱️ 0.0 years remaining

7-substituted amino-1-aryl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and derivatives thereof as antibacterial agents

Assignee: Warner Lambert Co LLC
•
Filing: 1985-01-25
•
Granted: 1986-10-14
•
Expires: 2005-01-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 1-aryl or heteroaryl-6,8-difluoro-1,4-dihydro-7-(3-aminomethyl)pyrrolidinyl- or 7-spiroamino-4-oxo-3-quinolinecarboxylic acids and acid derivatives thereof as antibacterial agents are described as well as methods for their manufacture, formulation and use in treating bacterial infections caused by Gram-negative and Gram-positive bacteria.

Inventors

  • 👤 Thomas F. Mich
  • 👤 John M. Domagala

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 14:35
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/04; C07D417/00; C07D417/14

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 82 words
A compound of the formula ##STR15## wherein Z is R 1 is hydrogen, alkyl having from one to six carbon atoms or a cation; R 2 is phenyl or phenyl substituted by halogen, alkyl, alkoxy, hydroxy, amino, monoalkylamino, dialkylamino or trifluoromethyl, 2-, 3-, or 4-pyridine, 2- or 3-thiophene, 2-imidazole, 2-oxazole or 2-thiazole; R 3 is hydrogen, alkyl having from one to four carbon atoms or cycloalkyl having three to six carbon atoms; or a pharmaceutically acceptable acid addition or base salt thereof.
Claim 2
Dependent Claim 82 words
A compound of the formula ##STR15## wherein Z is R 1 is hydrogen, alkyl having from one to six carbon atoms or a cation; R 2 is phenyl or phenyl substituted by halogen, alkyl, alkoxy, hydroxy, amino, monoalkylamino, dialkylamino or trifluoromethyl, 2-, 3-, or 4-pyridine, 2- or 3-thiophene, 2-imidazole, 2-oxazole or 2-thiazole; R 3 is hydrogen, alkyl having from one to four carbon atoms or cycloalkyl having three to six carbon atoms; or a pharmaceutically acceptable acid addition or base salt thereof.
Claim 3
Dependent Claim 19 words
A compound as claimed in claim 1, wherein R 1 is hydrogen or a pharmaceutically acceptable base salt thereof.
Claim 4
Dependent Claim 19 words
A compound as claimed in claim 2, wherein Z is ##STR16## and R 3 is hydrogen, methyl, or ethyl.
Claim 5
Dependent Claim 21 words
A compound as claimed in claim 3, wherein R 2 is p-fluorophenyl, p-aminophenyl, p-monoalkylaminophenyl, p-dialkylaminophenyl, 2-, 3-, or 4-pyridine, or 2-thiazole.
Claim 6
Dependent Claim 22 words
A compound as claimed in claim 2, wherein Z is ##STR17## in which R 3 is hydrogen, methyl, ethyl, 1- or 2-propyl.
Claim 7
Dependent Claim 21 words
A compound as claimed in claim 5, wherein R 2 is p-fluorophenyl, p-aminophenyl, p-monoalkylaminophenyl, p-dialkylaminophenyl, 2-, 3-, or 4-pyridine, or 2-thiazole.
Claim 8
Dependent Claim 11 words
A compound as claimed in claim 6, and being 7-[3[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-dihydro-4-oxo-1-phenyl-3-quinoline-carboxylic acid.
Claim 9
Dependent Claim 11 words
A compound as claimed in claim 6, and being 7-[3-(aminomethyl)-1-pyrrolidinyl]-6,8-difluoro-1,4-dihydro-4-oxo-1-phenyl-3-quinoline-carboxylic acid.
Claim 10
Dependent Claim 11 words
A compound as claimed in claim 6, and being 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8-difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid.
Claim 11
Dependent Claim 11 words
A compound as claimed in claim 6 and being 7-[3-(aminomethyl)-1-pyrrolidinyl]-6,8-difluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid.
Claim 12
Dependent Claim 22 words
A pharmaceutical composition comprising an antibacterially effective amount of a compound as claimed in claim 1 together with a pharmaceutically acceptable carrier.
Claim 13
Dependent Claim 22 words
The method of treating bacterial infections in mammals which comprises administering to said mammal a pharmaceutical composition as claimed in claim 11.

References Cited (Backward Citations)

GB1147336A Cited
JPS5186476A Cited
JPS5540656A Cited
US4398029A Cited
US4398029B1 Cited
US4530930A Cited
EP0131839A1 Cited
US4550103A Cited
US4550104A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-10-13 1990-04-14 1990-10-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-10-13 1994-04-14 1994-10-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-10-13 1998-04-14 1998-10-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag